HARROW, INC. — Director's Dealing 2013

Mar 16, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-12-31

Reporting Person: Schupp Joachim PH (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-12-15	Employee Stock Option (Right to Buy)	$4	A	493	Acquired	2014-12-15	Common Stock (493)	Direct
2012-02-28	Employee Stock Option (Right to Buy)	$3.6	A	75000	Acquired	2016-02-28	Common Stock (75000)	Direct

Footnotes

F1: The stock option was granted under the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan") and vests over a three year period, with 1/36th of the total number of options vesting each monthly period beginning on March 15, 2012. The option was approved by the Issuer's Board of Directors on February 15, 2012, subject to shareholder approval of an amendment to the Plan, which was obtained on February 28, 2012.